vimarsana.com
Home
Live Updates
Everest Medicines' Partner Calliditas Presents New Data from
Everest Medicines' Partner Calliditas Presents New Data from
Everest Medicines' Partner Calliditas Presents New Data from the NefIgArd Phase 3 Trial at the 17th International Symposium on IgA Nephropathy Tokyo 2023
/PRNewswire/ -- Everest Medicines' (HKEX 1952.HK, "Everest", or the "Company") partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX)...
Related Keywords
Macau ,
Tokyo ,
Japan ,
Singapore ,
United Kingdom ,
United States ,
Shanghai ,
China ,
Stockholm ,
Sweden ,
South Korea ,
Taiwan ,
Hong Kong ,
Chinese ,
Rogers Yongqing Luo ,
European Union ,
International Symposium On Iga Nephropathy ,
Calliditas Therapeutics ,
Nasdaq Stockholm ,
International Symposium ,
Iga Nephropathy ,
Chief Executive Officer ,
Priority Review ,
Breakthrough Therapy Designation ,
Shanghai Ruijin Hospital ,
Everest Medicines ,
Mainland China ,
Everest Medicine ,